FIGO stage III and IV uterine papillary serous carcinoma: Impact of residual disease on survival

S. Memarzadeh; C. H. Holschneider; R. E. Bristow; N. L. Jones; Y. S. Fu; B. Y. Karlan; J. S. Berek; R. Farias-Eisner

doi:10.1046/j.1525-1438.2002.01149.x

FIGO stage III and IV uterine papillary serous carcinoma: Impact of residual disease on survival

S. Memarzadeh, C. H. Holschneider, R. E. Bristow, N. L. Jones, Y. S. Fu, B. Y. Karlan, J. S. Berek, R. Farias-Eisner

School of Medicine

Research output: Contribution to journal › Article › peer-review

55 Scopus citations

Abstract

The objective of this study was to assess the impact of surgical cytoreduction on the survival of patients with uterine papillary serous carcinoma (UPSC). Patients added to the institutional tumor registries between January 1980 and September 2001 with the diagnosis of UPSC were reviewed. The records of 43 patients who underwent surgical cytoreduction for FIGO stage III and IV disease were reviewed. The median survival of UPSC patients with microscopic residual disease was significantly improved compared to those with macroscopic residual disease following primary surgical cytoreduction. We conclude that primary surgical cytoreduction resulting in microscopic residual disease is associated with an improvement in recurrence-free survival and overall survival in women with UPSC.

Original language	English (US)
Pages (from-to)	454-458
Number of pages	5
Journal	International Journal of Gynecological Cancer
Volume	12
Issue number	5
DOIs	https://doi.org/10.1046/j.1525-1438.2002.01149.x
State	Published - Sep 1 2002

Keywords

Primary surgical cytoreduction
Survival
Uterine papillary serous carcinoma

ASJC Scopus subject areas

Oncology
Obstetrics and Gynecology

Access to Document

10.1046/j.1525-1438.2002.01149.x

Cite this

@article{b9ea9c315e3b44b281b0eb0af682b6d0,

title = "FIGO stage III and IV uterine papillary serous carcinoma: Impact of residual disease on survival",

abstract = "The objective of this study was to assess the impact of surgical cytoreduction on the survival of patients with uterine papillary serous carcinoma (UPSC). Patients added to the institutional tumor registries between January 1980 and September 2001 with the diagnosis of UPSC were reviewed. The records of 43 patients who underwent surgical cytoreduction for FIGO stage III and IV disease were reviewed. The median survival of UPSC patients with microscopic residual disease was significantly improved compared to those with macroscopic residual disease following primary surgical cytoreduction. We conclude that primary surgical cytoreduction resulting in microscopic residual disease is associated with an improvement in recurrence-free survival and overall survival in women with UPSC.",

keywords = "Primary surgical cytoreduction, Survival, Uterine papillary serous carcinoma",

author = "S. Memarzadeh and Holschneider, {C. H.} and Bristow, {R. E.} and Jones, {N. L.} and Fu, {Y. S.} and Karlan, {B. Y.} and Berek, {J. S.} and R. Farias-Eisner",

year = "2002",

month = sep,

day = "1",

doi = "10.1046/j.1525-1438.2002.01149.x",

language = "English (US)",

volume = "12",

pages = "454--458",

journal = "International Journal of Gynecological Cancer",

issn = "1048-891X",

publisher = "Elsevier Inc.",

number = "5",

}

TY - JOUR

T1 - FIGO stage III and IV uterine papillary serous carcinoma

T2 - Impact of residual disease on survival

AU - Memarzadeh, S.

AU - Holschneider, C. H.

AU - Bristow, R. E.

AU - Jones, N. L.

AU - Fu, Y. S.

AU - Karlan, B. Y.

AU - Berek, J. S.

AU - Farias-Eisner, R.

PY - 2002/9/1

Y1 - 2002/9/1

N2 - The objective of this study was to assess the impact of surgical cytoreduction on the survival of patients with uterine papillary serous carcinoma (UPSC). Patients added to the institutional tumor registries between January 1980 and September 2001 with the diagnosis of UPSC were reviewed. The records of 43 patients who underwent surgical cytoreduction for FIGO stage III and IV disease were reviewed. The median survival of UPSC patients with microscopic residual disease was significantly improved compared to those with macroscopic residual disease following primary surgical cytoreduction. We conclude that primary surgical cytoreduction resulting in microscopic residual disease is associated with an improvement in recurrence-free survival and overall survival in women with UPSC.

AB - The objective of this study was to assess the impact of surgical cytoreduction on the survival of patients with uterine papillary serous carcinoma (UPSC). Patients added to the institutional tumor registries between January 1980 and September 2001 with the diagnosis of UPSC were reviewed. The records of 43 patients who underwent surgical cytoreduction for FIGO stage III and IV disease were reviewed. The median survival of UPSC patients with microscopic residual disease was significantly improved compared to those with macroscopic residual disease following primary surgical cytoreduction. We conclude that primary surgical cytoreduction resulting in microscopic residual disease is associated with an improvement in recurrence-free survival and overall survival in women with UPSC.

KW - Primary surgical cytoreduction

KW - Survival

KW - Uterine papillary serous carcinoma

UR - http://www.scopus.com/inward/record.url?scp=0036742609&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036742609&partnerID=8YFLogxK

U2 - 10.1046/j.1525-1438.2002.01149.x

DO - 10.1046/j.1525-1438.2002.01149.x

M3 - Article

C2 - 12366662

AN - SCOPUS:0036742609

SN - 1048-891X

VL - 12

SP - 454

EP - 458

JO - International Journal of Gynecological Cancer

JF - International Journal of Gynecological Cancer

IS - 5

ER -

FIGO stage III and IV uterine papillary serous carcinoma: Impact of residual disease on survival

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this